Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations (Q36422375)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1, 1997

edit

Language	Label	Description	Also known as
English	Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations	scientific article published on January 1, 1997

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

2223787

retrieved

14 August 2017

title

Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

2223787

retrieved

14 August 2017

main subject

phase I clinical trial

0 references

Japan

1 reference

based on heuristic

inferred from title

questionnaire

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9218741

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218741

retrieved

14 September 2024

author name string

K. Itoh

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9218741

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218741

retrieved

14 September 2024

Y. Sasaki

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9218741

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218741

retrieved

14 September 2024

H. Fujii

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9218741

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218741

retrieved

14 September 2024

T. Ohtsu

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9218741

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218741

retrieved

14 September 2024

H. Wakita

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9218741

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218741

retrieved

14 September 2024

T. Igarashi

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9218741

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218741

retrieved

14 September 2024

K. Abe

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9218741

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218741

retrieved

14 September 2024

language of work or name

English

0 references

publication date

1 January 1997

1 reference

stated in

Europe PubMed Central

PMC publication ID

2223787

retrieved

14 August 2017

full work available at URL

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223787

file format

HTML

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9218741

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218741

retrieved

14 September 2024

https://europepmc.org/articles/PMC2223787

file format

HTML

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9218741

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218741

retrieved

14 September 2024

https://europepmc.org/articles/PMC2223787?pdf=render

file format

Portable Document Format

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9218741

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218741

retrieved

14 September 2024

http://www.nature.com/articles/bjc1997344.pdf

file format

Portable Document Format

1 reference

stated in

Crossref

DOI

10.1038/BJC.1997.344

reference URL

https://api.crossref.org/works/10.1038/BJC.1997.344

retrieved

14 September 2024

http://www.nature.com/articles/bjc1997344

1 reference

stated in

Crossref

DOI

10.1038/BJC.1997.344

reference URL

https://api.crossref.org/works/10.1038/BJC.1997.344

retrieved

14 September 2024

published in

British Journal of Cancer

1 reference

stated in

Europe PubMed Central

PMC publication ID

2223787

retrieved

14 August 2017

volume

76

1 reference

stated in

Europe PubMed Central

PMC publication ID

2223787

retrieved

14 August 2017

issue

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

2223787

retrieved

14 August 2017

page(s)

107-113

1 reference

stated in

Europe PubMed Central

PMC publication ID

2223787

retrieved

14 August 2017

cites work

Factors affecting quality of informed consent

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223787

retrieved

30 September 2017

Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223787

retrieved

30 September 2017

Responses and toxic deaths in phase I clinical trials

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223787

retrieved

30 September 2017

Choice of starting dose and escalation for phase I studies of antitumor agents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223787

retrieved

30 September 2017

Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223787

retrieved

30 September 2017

Patient motivation and informed consent in a phase I study of an anticancer agent

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223787

retrieved

28 June 2018

Informing patients about phase I trials--how should it be done?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223787

retrieved

28 June 2018

Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223787

retrieved

21 September 2018

Perceptions of cancer patients and their physicians involved in phase I trials

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223787

retrieved

21 September 2018

Informed consent -- why are its goals imperfectly realized?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223787

retrieved

21 September 2018

Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223787

retrieved

21 October 2018

Informed consent for investigational chemotherapy: patients' and physicians' perceptions

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223787

retrieved

21 October 2018

On the nature and ethics of phase I clinical trials of cancer chemotherapies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223787

retrieved

4 December 2018

Do-Not-Resuscitate Orders at a Teaching Hospital in Japan

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9218741

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic response in phase I trials of antineoplastic agents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9218741

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response rates, duration of response, and dose response effects in phase I studies of antineoplastics

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9218741

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic response and potential pitfalls in phase I clinical trials of anticancer agents conducted in Japan

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9218741

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is informed consent essential for all chemotherapy studies?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9218741

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/BJC.1997.344

1 reference

stated in

Europe PubMed Central

PMC publication ID

2223787

retrieved

14 August 2017

Dimensions Publication ID

1029432874

0 references

PMC publication ID

2223787

1 reference

stated in

Europe PubMed Central

PMC publication ID

2223787

retrieved

14 August 2017

PubMed publication ID

9218741

1 reference

stated in

Europe PubMed Central

PMC publication ID

2223787

retrieved

14 August 2017

ResearchGate publication ID

14000308

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36422375&oldid=2249078358"